XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.160
-0.022 (-1.86%)
At close: Jun 27, 2025, 4:00 PM
1.180
+0.020 (1.72%)
After-hours: Jun 27, 2025, 4:00 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $10.41 million as of June 27, 2025. Its market cap has decreased by -29.06% in one year.
Market Cap
10.41M
Enterprise Value
9.36M
1-Year Change
-29.06%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $10.41M, a decrease of -94.21%. That is a compound annual growth rate of -13.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.40B |
| Johnson & Johnson | 367.31B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 274.19B |
| Abbott Laboratories | 239.61B |
| Novartis AG | 231.01B |
| AstraZeneca | 218.32B |